{"name":"Methoxamine","slug":"methoxamine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Methoxamin","Methoxamedrine","Pseudomethoxamine","Metossamina","Benzenemethanol, α-(1-aminoethyl)-2,5-dimethoxy-","Nrl001","Nrl-001","Methoxamedrin","Vasoxin","Wellcome, Metoxamine"],"brands":[],"scraped":true,"has_structure":true,"cid":6082,"classes":[{"name":"sympathomimetic","href":"/class/sympathomimetic"}],"families":[{"name":"amphetamine","href":"/substituted/amphetamine"},{"name":"phenylethanolamine","href":"/substituted/phenylethanolamine"}],"physical":[{"label":"Molecular mass","value":"211.26 g/mol","copyable":false},{"label":"Solubility","value":"Soluble (185 g/L)","copyable":false},{"label":"Predicted LogP","value":"0.5","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>11</sub>H<sub>17</sub>NO<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol","copyable":true},{"label":"SMILES","value":"CC(C(C1=C(C=CC(=C1)OC)OC)O)N","copyable":true},{"label":"InChI","value":"InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3","copyable":true},{"label":"InChIKey","value":"WJAJPNHVVFWKKL-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"390-28-3","copyable":true},{"label":"PubChem CID","value":"6082","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"3 hours","copyable":false},{"label":"Excretion","value":"Urine","copyable":false},{"label":"Routes of administration","value":"Oral, injection","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"diastereomer","optical_activity":null,"stereoisomers":[{"name":"(1R,2R)-Methoxamine","href":"/substance/%281r,2r%29-methoxamine"},{"name":"Methoxamine, (-)-","href":"/substance/methoxamine,_%28-%29-"},{"name":"(1S,2R)-Methoxamine","href":"/substance/%281s,2r%29-methoxamine"},{"name":"(1S,2S)-Methoxamine","href":"/substance/%281s,2s%29-methoxamine"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"C","description":"Cardiovascular system"},{"code":"C01","description":"Cardiac therapy"},{"code":"C01C","description":"Cardiac stimulants excl. cardiac glycosides"},{"code":"C01CA","description":"Adrenergic and dopaminergic agents"},{"code":"C01CA10","description":"Methoxamine"}],"mesh":[{"name":"Sympathomimetics","id":"M0020947"},{"name":"Vasoconstrictor Agents","id":"M0022551"},{"name":"Adrenergic alpha-1 Receptor Agonists","id":"M0543920"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"ADRA1A","mechanisms":["shared target"],"partners":3,"contraindicated":1},{"target":"ADRA1B","mechanisms":["shared target"],"partners":3,"contraindicated":1},{"target":"ADRA1D","mechanisms":["shared target"],"partners":3,"contraindicated":1}],"mechanism":"Methoxamine acts through peripheral vasoconstriction by acting as a pure alpha-1 adrenergic receptor agonist, consequently increasing systemic blood pressure (both systolic and diastolic).","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Restless legs","Shakiness","Stamina enhancement","Vasoconstriction"]],["Cognitive Effects",["Thought acceleration","Wakefulness"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Methoxamine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/6082"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q685119"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00723"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL524"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A6839"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=390-28-3"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014861"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07513"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID0023290"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Methoxamine"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 6082, Methoxamine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/6082>https://pubchem.ncbi.nlm.nih.gov/compound/6082</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 09:01:08","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"no Erowid substance of that name"},{"source":"gsrs","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"no UNII"},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"hmdb.ca refused automated access to HMDB0014861"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 09:01:05","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 09:01:01","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 09:01:04","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 09:01:04","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 09:01:04","note":null}],"description":"Methoxamine is a sympathomimetic substance."}